Isabelle Racamier is Chief Executive Officer of EsoCap AG. Isabelle Racamier is an accomplished healthcare executive in the biopharmaceutical industry.
Isabelle Racamier has 25 years of experience in the pharmaceutical and biotechnology industries, in controlling, strategic planning, marketing and general management. Isabelle Racamier has held increasingly responsible positions in France, Switzerland, the USA, Japan and Austria with Novartis, Boehringer Mannheim (now part of Roche) and Sanofi. She was the General Manager of Sanofi in Austria from 1998 to 2005, consistently generating yearly double-digit growth during this time. Isabelle Racamier served as a Board member of the Franco-Austrian Chamber of Commerce from 2002 to 2009.
From 2016 onwards Isabelle Racamier was a Board member of Genomic Vision, a molecular diagnostic company listed on the French stock exchange. From mid-July 2018 to January 2020 she served as a President of the Supervisory Board.
Isabelle Racamier earned her Master’s in Management from ESCP-Europe in Paris. She received executive training in Marketing at INSEAD and in Corporate Governance at the COLUMBIA Business School.